Neurology

The Pharmacy Times® Neurology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?

Study: Daily Low-Dose Aspirin Does Not Reduce the Risk of Probable Alzheimer Disease

A study by the American Academy of Neurology suggests that taking a low-dose aspirin once per day does not reduce the risk of thinking and memory problems caused by mild cognitive impairment or possible Alzheimer disease.

Ozanimod Approved by FDA for Treatment of Relapsing Forms of Multiple Sclerosis

Ozanimod demonstrated acceptable safety and tolerability in the phase 3 SUNBEAM and RADIANCE part B trials.

Study: Moderate Lifetime Alcohol Intake May Have Beneficial Effect on Alzheimer Disease

The study focused on whether moderate alcohol intake is related to reductions in amyloid-beta deposition or is protective via amyloid-independent mechanisms in the living human brain since little information was available.

Diazepam Nasal Spray Available for Seizure Cluster Rescue

The spray is the first nasal spray treatment for seizure cluster rescue.

CDC Makes Recommendations for Preserving Brain Health

Few drugs are available to address cognitive decline, but dietary changes, mental and physical activity, and social engagement can all help.

CDC Makes Recommendations for Preserving Brain Health

Few drugs are available to address cognitive decline, but dietary changes, mental and physical activity, and social engagement can all help.

Dietary Interventions Build a Healthy Brain

Higher dietary intake of flavonols may be associated with a lower risk of developing Alzheimer dementia.

Fibromyalgia Treatment Requires Medication Trial and Error

Many options are available, but no single one is effective for all symptoms of this disorder.

FDA Approves Rimegepant for the Treatment of Migraine in Adults

The medication works by blocking CGRP receptors, treating a root cause of migraine.

Monday Pharmaceutical Mystery: February 24

Why is KM taking such a high dose of prednisone?

Reduction in Dietary Methionine May Achieve Better Outcomes for Patients with Multiple Sclerosis

Study findings provide further basis for dietary interventions as future treatments for disorders such as multiple sclerosis.

Multiple Sclerosis Drug Costs Nearly Tripled Over 7 Years

The release of generic versions of brand name drugs for patients with multiple sclerosis had little overall effect on the price increase.

The Pharmacy Times® Neurology resource center provides a home for all of the latest clinical information that both neurologists and pharmacists that work within the field could find valuable. With articles covering updates from the robust pipeline of novel neurological therapies, and the newest data from all phases of clinical trials and studies in the space, it also serves as a hub of coverage from ongoing conferences and annual meetings of neurological associations.